Table 2 CT-Severity scores in each group of patients according status of immunization and general health with ANOVA

Patients with good general health and absent co-morbidity

Score 0 (Clear lungs)

25 (23%)

35 (56%)

27 (71%)

18 (69%)

Score 1 (1–25%)

82 (74%)

26 (41%)

10 (26%)

8 (31%)

Score 2 (26–50%)

1 (1%)

1 (1.5%)

1 (3%)

0

Score 3 (51–75%)

1 (1%)

1 (1.5%)

0

0

Score 4 (76–100%)

1 (1%)

0

0

0

Mean

0.69091

0.49206

0.31579

0.30769

Standard deviation

0.63166

0.61887

0.52532

0.47068

Normality

1.066e−14

2.368e−10

7.953e−9

1.798e−7

Skewness

1.467299

1.295957

1.403173

0.885246

Excess kurtosis

6.718522

2.725637

1.126072

− 1.324728

Total

110 (100%)

63 (100%)

38 (100%)

26 (100%)

Patients with chronic co-morbidity

Score 0 (Clear lungs)

5 (16%)

2 (11%)

7 (58%)

4 (67%)

Score 1 (1–25%)

22 (69%)

15 (79%)

4 (33%)

2 (33%)

Score 2 (26–50%)

2 (6%)

1 (5%)

1 (9%)

0

Score 3 (51–75%)

1 (3%)

1 (5%)

0

0

Score 4 (76–100%)

2 (6%)

0

0

0

Mean

1.15625

1.05263

0.5

0.33333

Standard deviation

0.95409

0.62126

0.6742

0.5164

Normality

4.273e–7

0.000008665

0.001741

0.005544

Skewness

1.80862

1.527857

1.067933

0.968246

Excess kurtosis

3.88361

5.618255

0.352

− 1.875

Total

32 (100%)

19 (100%)

12 (100%)

6 (100%)

Immunocompromised patients

Score 0 (Clear lungs)

0

1 (10%)

3 (60%)

4 (67%)

Score 1 (1–25%)

3 (21%)

4 (40%)

1 (20%)

1 (17%)

Score 2 (26–50%)

5 (36%)

2 (20%)

1 (20%)

1 (17%)

Score 3 (51–75%)

4 (29%)

2 (20%)

0

0

Score 4 (76–100%)

2 (15%)

1 (10%)

0

0

Mean

2.35714

1.8

0.6

0.5

Standard deviation

1.00821

1.22927

0.89443

0.83666

Normality

0.09644

0.4046

0.06792

0.01418

Skewness

0.19301

0.46656

1.257788

1.536722

Excess kurtosis

− 0.819417

− 0.543592

0.3125

1.428571

Total

14 (100%)

10 (100%)

5 (100%)

6 (100%)